Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 13/20 | 0.64 |
| ▸ | CA2 | P00918 | 13/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 4/20 | 0.56 |
| ▸ | CA9 | Q16790 | 4/20 | 0.56 |
| ▸ | CA4 | P22748 | 4/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9639810 | 0.94 | HDAC1 (0.59) | CA1CA2TSHRHDAC1EPHX2 | |
| SCHEMBL4268752 | 0.91 | CA1 (0.67) | CA1CA2ALOX15TSHRCYP2C19 | |
| SCHEMBL4272357 | 0.91 | CA1 (0.67) | CA1CA2ALOX15TSHRCYP2C19 | |
| SCHEMBL4365925 | 0.86 | HDAC1 (0.65) | CA1CA2TSHRCA12CA9 | |
| SCHEMBL17883376 | 0.84 | CA1 (0.53) | CA1CA2ALOX15TSHRCYP2C19 | |
| SCHEMBL9515833 | 0.84 | CA2 (0.63) | CA1CA2ALOX15TSHRCYP2C19 | |
| SCHEMBL9514501 | 0.84 | CA1 (0.68) | CA1CA2ALOX15TSHRCYP2C19 | |
| SCHEMBL9617679 | 0.84 | BCHE (0.62) | CA1CA2ALOX15TSHRCYP2C19 | |
| SCHEMBL15499792 | 0.83 | CA1 (0.75) | CA1CA2ALOX15TSHRCYP2C19 | |
| SCHEMBL8623174 | 0.83 | ALDH1A1 (0.68) | HDAC1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0133603-A1 | Specific relaxation agents for organs or pathologics for use in modifying the contrast of medical imagery by nuclear magnetic resonance | Société anonyme: COMPAGNIE ORIS INDUSTRIE (FR) | 1985-02-27 | — | — | EP | claimed |
| US-9040129-B2 | Protective film of polarizer, polarizer and method for producing it, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2015-05-26 | — | — | US | disclosed |
| US-20150055062-A1 | OPTICAL FILM, POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2015-02-26 | — | — | US | disclosed |
| US-8394309-B2 | Resin film and method for producing it, polarizer and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2013-03-12 | — | — | US | disclosed |
| US-8337962-B2 | Resin film and method for producing it, polarizer and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2012-12-25 | — | — | US | disclosed |
| US-20120153542-A1 | RESIN FILM AND METHOD FOR PRODUCING IT, POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20110273646-A1 | Protective film of polarizer, polarizer and method for producing it, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110223435-A1 | RESIN FILM AND METHOD FOR PRODUCING IT, POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2011-09-15 | — | — | US | disclosed |
| US-4804529-A | Use of specific relaxation agents for organs or pathologies for modifying the contrasts in medical imaging by nuclear magnetic resonance | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1989-02-14 | — | — | US | disclosed |
| EP-0133603-A1 | Specific relaxation agents for organs or pathologics for use in modifying the contrast of medical imagery by nuclear magnetic resonance | Société anonyme: COMPAGNIE ORIS INDUSTRIE (FR) | 1985-02-27 | — | — | EP | disclosed |